Pharmacogenetic testing prior to carbamazepine treatment of epilepsy: patients' and physicians' preferences for testing and service delivery

AIM: Pharmacogenetic studies have identified the presence of the HLA-A*31:01 allele as a predictor of cutaneous adverse drugs reactions (ADRs) to carbamazepine. This study aimed to ascertain the preferences of patients and clinicians to inform carbamazepine pharmacogenetic testing services. METHODS:...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Br J Clin Pharmacol
मुख्य लेखकों: Powell, Graham, Holmes, Emily A F, Plumpton, Catrin O, Ring, Adele, Baker, Gus A, Jacoby, Ann, Pirmohamed, Munir, Marson, Anthony G, Hughes, Dyfrig A
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: John Wiley & Sons, Ltd 2015
विषय:
Pharmacogenetics
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC4631187/
https://ncbi.nlm.nih.gov/pubmed/26138622
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12715
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन